Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Hair color is not a risk factor for developing alopecia areata.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Living with lupus as both a patient and doctor improved understanding and care for others.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Take care of your hair as much as your face for a youthful look.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

PRP is popular for hair restoration but needs better research methods to confirm its effectiveness and safety.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Public interest in oral minoxidil for hair loss increased after a New York Times article.

Post-finasteride syndrome's existence is uncertain; more research needed.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Hair loss in elderly people is often due to health issues and needs better diagnosis and treatment.

Certain hairstyles can cause scalp diseases, smoking is linked to hair loss, 5% minoxidil foam is effective for hair loss treatment, and various factors influence wound healing and hair growth.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

UK postgraduate health students have limited understanding of alopecia, with many misconceptions, highlighting the need for better awareness.